Published in N Engl J Med on February 04, 1999
Cell-mediated immune responses in tuberculosis. Annu Rev Immunol (2009) 5.90
Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med (2011) 3.27
Tuberculosis and HIV co-infection. PLoS Pathog (2012) 2.57
Clinical and laboratory observations of tuberculosis at a Mumbai (India) clinic. Postgrad Med J (2004) 2.36
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
Urogenital tuberculosis: update and review of 8961 cases from the world literature. Rev Urol (2008) 1.72
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol (2002) 1.57
Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol (2000) 1.44
Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.43
Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci U S A (2009) 1.38
Site of extrapulmonary tuberculosis is associated with HIV infection. Clin Infect Dis (2012) 1.34
Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, northern Nigeria. J Epidemiol (2009) 1.27
Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun (2001) 1.27
Tuberculosis vaccines in clinical trials. Expert Rev Vaccines (2011) 1.26
Risk factors for mortality among patients with extrapulmonary tuberculosis at an academic inner-city hospital in the US. Eur J Epidemiol (2006) 1.23
Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect Immun (2001) 1.21
Impact of HIV infection on tuberculosis. Postgrad Med J (2000) 1.20
HIV-associated opportunistic pneumonias. Respirology (2009) 1.19
Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infect Immun (2002) 1.17
Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa. Trop Med Int Health (2012) 1.12
Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One (2010) 1.08
Mycobacterium marinum causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish. PLoS Pathog (2012) 1.07
The transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach. Epidemiol Infect (2008) 1.07
The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Philos Trans R Soc Lond B Biol Sci (2014) 1.06
Clinical characteristics of tuberculosis-associated immune reconstitution inflammatory syndrome in North Indian population of HIV/AIDS patients receiving HAART. Clin Dev Immunol (2010) 1.03
Increased Mycobacterium tuberculosis growth in HIV-1-infected human macrophages: role of tumour necrosis factor-alpha. Clin Exp Immunol (2001) 1.01
Interferon γ responses to mycobacterial antigens protect against subsequent HIV-associated tuberculosis. J Infect Dis (2010) 1.00
Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in Tanzania. Vaccine (2010) 0.99
The production of consumption: addressing the impact of mineral mining on tuberculosis in southern Africa. Global Health (2009) 0.98
Manifestation of tuberculosis in patients with human immunodeficiency virus: a large Indian study. Ann Thorac Med (2007) 0.97
HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in Peru. Epidemiol Infect (2007) 0.94
Tuberculosis and HIV disease: two decades of a dual epidemic. Wien Klin Wochenschr (2003) 0.93
Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection. J Exp Med (2015) 0.93
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PLoS One (2012) 0.91
A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine (2009) 0.90
Mining and risk of tuberculosis in sub-Saharan Africa. Am J Public Health (2010) 0.89
Immune recovery after starting ART in HIV-infected patients presenting and not presenting with tuberculosis in South Africa. J Acquir Immune Defic Syndr (2013) 0.89
Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res Notes (2012) 0.89
Prevalence of mycobacteremia in Indian HIV-infected patients detected by the MB/BacT automated culture system. Eur J Clin Microbiol Infect Dis (2008) 0.88
Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis. Mol Immunol (2009) 0.87
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC Infect Dis (2011) 0.87
Aerosol immunisation for TB: matching route of vaccination to route of infection. Trans R Soc Trop Med Hyg (2015) 0.86
Therapeutic drug monitoring in a developing country: an overview. Br J Clin Pharmacol (1999) 0.86
Incidence and risk factors of tuberculosis in patients with human immunodeficiency virus infection. J Korean Med Sci (2013) 0.86
Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish. PLoS Pathog (2014) 0.83
Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs. BMC Med (2011) 0.82
Imaging lung manifestations of HIV/AIDS. Ann Thorac Med (2010) 0.82
Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection. Front Immunol (2013) 0.82
Tuberculosis among foreign-born children in the state of Florida, 1993-1999: a re-emergence phase after a sustained decline? Wien Klin Wochenschr (2003) 0.81
Foreign-Born Status and Geographic Patterns of Tuberculosis Genotypes in Tarrant County, Texas. Prof Geogr (2008) 0.80
Introduction: 'dying for gold': the effects of mineral miningon HIV, tuberculosis, silicosis, and occupational diseases in southern Africa. Int J Health Serv (2013) 0.80
Tuberculosis screening and active tuberculosis among HIV-infected persons in a Canadian tertiary care centre. Can J Infect Dis Med Microbiol (2009) 0.78
Inflammatory status hepatic enzymes and serum creatinine in HIV-, HIV+ and HIV-TB co-infected adult Central Africans. Int J Gen Med (2012) 0.77
Greater preexisting interferon γ responses to mycobacterial antigens and lower bacillary load during HIV-associated tuberculosis. J Infect Dis (2013) 0.76
Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients. Eur J Clin Microbiol Infect Dis (2010) 0.76
Tuberculosis at the beginning of the third millennium: one disease, three epidemics. Eur Radiol (2003) 0.75
Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection. PLoS One (2017) 0.75
A young man with an expanding neck mass. CMAJ (2004) 0.75
Ocular Lesions Associated with Human Immunodeficiency Virus Infection. Med J Armed Forces India (2011) 0.75
Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, Peru. Am J Trop Med Hyg (2016) 0.75
An IMS/ATP Assay for the Detection of Mycobacterium tuberculosis in Urine. Tuberc Res Treat (2012) 0.75
Pulmonary tuberculosis and SARS, China. Emerg Infect Dis (2006) 0.75
Immune reconstitution and inflammatory syndrome due to disseminated tuberculosis in a case of human immunodeficiency virus 2 infection. Indian J Pharmacol (2011) 0.75
Genital tuberculosis: current status of diagnosis and management. Transl Androl Urol (2017) 0.75
Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med (2017) 0.75
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis (1993) 4.01
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun (1995) 2.57
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States. J Clin Microbiol (1998) 2.49
Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Am J Med (1990) 2.35
Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis (1999) 2.29
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med (1997) 1.76
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun (1998) 1.74
Clinical correlates of interferon gamma production in patients with tuberculosis. Clin Infect Dis (1997) 1.70
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65
Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun (1998) 1.58
Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med (2001) 1.53
Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. J Clin Microbiol (1996) 1.52
Absence of a prominent Th2 cytokine response in human tuberculosis. Infect Immun (1996) 1.51
Relationship of isoniazid resistance to human immunodeficiency virus infection in patients with tuberculosis. Am J Respir Crit Care Med (1996) 1.43
Undiagnosed tuberculosis in patients with human immunodeficiency virus infection. Chest (1990) 1.41
Rapid diagnostic tests for tuberculosis: progress but no gold standard. Am J Respir Crit Care Med (1997) 1.40
CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis. Clin Infect Dis (1997) 1.32
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30
Production of monocyte chemoattractant protein 1 in tuberculosis patients. Infect Immun (1998) 1.29
Mycobacterial disease in patients with human immunodeficiency virus infection. Arch Intern Med (1989) 1.15
Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis (2001) 1.15
Evidence from molecular fingerprinting of limited spread of drug-resistant tuberculosis in Texas. J Clin Microbiol (1999) 1.13
The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions. J Immunol (1991) 1.11
Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J Infect Dis (2000) 1.10
Evidence for a superantigen in human tuberculosis. Immunity (1994) 1.10
Enhanced production of recombinant Mycobacterium tuberculosis antigens in Escherichia coli by replacement of low-usage codons. Infect Immun (2000) 1.08
Antimycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest (1990) 1.07
Pleuritis as a manifestation of reactivation tuberculosis. Am J Med (1990) 1.06
Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease. J Infect Dis (1996) 1.05
Depressed CD40 ligand expression contributes to reduced gamma interferon production in human tuberculosis. Infect Immun (2000) 1.04
Potentiation of the macrophage 25-hydroxyvitamin D-1-hydroxylation reaction by human tuberculous pleural effusion fluid. J Clin Endocrinol Metab (1989) 1.02
Testing for human immunodeficiency virus infection among tuberculosis patients in Los Angeles. Am J Respir Crit Care Med (1997) 1.02
Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis. J Immunol (1999) 0.98
Six cases of Mycobacterium tuberculosis bacteremia. J Infect Dis (1987) 0.95
Medical treatment of hepatic amebic abscess: rare need for percutaneous drainage. Radiology (1987) 0.95
Yield of bronchoscopy for the diagnosis of tuberculosis in patients with human immunodeficiency virus infection. Chest (1992) 0.95
Effects of Mycobacterium tuberculosis on the bioelectric properties of the alveolar epithelium. Infect Immun (1997) 0.94
A case of melioidosis originating in North America. Am Rev Respir Dis (1986) 0.94
Sonographic features of amebic and pyogenic liver abscesses: a blinded comparison. AJR Am J Roentgenol (1987) 0.94
The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis (1987) 0.93
The immunology of tuberculous pleurisy. Semin Respir Infect (1988) 0.92
Type 1 cytokines and the pathogenesis of tuberculosis. Am J Respir Crit Care Med (2000) 0.91
Production of interleukin-18 in human tuberculosis. J Infect Dis (2000) 0.90
Abdominal tuberculosis in patients infected with the human immunodeficiency virus. Clin Infect Dis (1995) 0.90
Isolation of mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J Clin Invest (1998) 0.90
Combined toxicity of zidovudine and antituberculosis chemotherapy. Am Rev Respir Dis (1992) 0.89
IL12 and the human immune response to mycobacteria. Res Immunol (1996) 0.89
Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis. Infect Immun (2001) 0.88
Reducing ongoing transmission of tuberculosis. JAMA (1998) 0.87
Cytokine production in children with tuberculous infection and disease. Clin Infect Dis (1999) 0.86
A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection. Am J Respir Crit Care Med (1994) 0.85
T cells enhance production of IL-18 by monocytes in response to an intracellular pathogen. J Immunol (2001) 0.83
Tuberculosis mimicking acute appendicitis in patients with human immunodeficiency virus infection. Clin Infect Dis (1994) 0.83
Immunohistology of tuberculous adenitis in symptomatic HIV infection. Clin Exp Immunol (1988) 0.83
Pediatric tuberculosis: clinical presentation and contact investigation at an urban medical center. Respiration (1998) 0.79
Role of fiberoptic bronchoscopy in diagnosis of pulmonary tuberculosis in patients at risk for AIDS. Chest (1993) 0.75
T-lymphocyte subpopulations in tuberculosis. Indian Pediatr (2000) 0.75
Cerebrospinal fluid cell counts and chemistries in bacterial meningitis. South Med J (1989) 0.75
Tuberculosis in patients with HIV infection who receive corticosteroids for presumed Pneumocystis carinii pneumonia. Am J Respir Crit Care Med (1994) 0.75